Market revenue in 2023 | USD 9.8 million |
Market revenue in 2030 | USD 18.4 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Transrectal |
Fastest growing segment | Transperineal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transrectal, Transperineal |
Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 85.71% in 2023. Horizon Databook has segmented the Mexico fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
Private healthcare services provider in Mexico dominate the healthcare industry. As of 2013, Mexico had over 4,466 hospitals, of which, around 67.0% are private and the remaining 33.0% are government hospitals. Mexico is one of the major exporters of medical products to North America and Europe. This offers significant growth opportunities for companies operating in Mexico’s fusion biopsy market.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Mexico fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account